{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:45:59Z","timestamp":1792597559638,"version":"4.5.0"},"reference-count":43,"publisher":"MyJove Corporation","issue":"220","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68477","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:01:02Z","timestamp":1751050862000},"source":"Crossref","is-referenced-by-count":1,"title":["Image-guided <em>In Vivo<\/em> Tracking of Transplanted Distal Lung Epithelial Progenitor Cells for Pulmonary Fibrosis Using Magnetic Particle Imaging"],"prefix":"10.3791","author":[{"given":"Saumya","family":"Nigam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manvir","family":"Bamrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara E.","family":"Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda E.","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kenyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JCN.0b013e318197a6a5","type":"journal-article","article-title":"Introduction to Stem Cell Therapy","volume":"24","author":"Biehl","year":"2009","unstructured":"Biehl, J. K., Russell, B. Introduction to Stem Cell Therapy. J Cardiovasc Nurs. 24 (2), 98-103 (2009).","journal-title":"J Cardiovasc Nurs"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1479-5876-9-29","type":"journal-article","article-title":"Risk factors in the development of stem cell therapy","volume":"9","author":"Herberts","year":"2011","unstructured":"Herberts, C. A., Kwa, M. S. G., Hermsen, H. P. H. Risk factors in the development of stem cell therapy. J Transl Med. 9 (1), 29 (2011).","journal-title":"J Transl Med"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/cncr.32659","type":"journal-article","article-title":"Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy","volume":"126","author":"Bair","year":"2020","unstructured":"Bair, S. M., Brandstadter, J. D., Ayers, E. C., Stadtmauer, E. A. Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy. Cancer. 126 (9), 1837-1855 (2020).","journal-title":"Cancer"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-020-01017-7","type":"journal-article","article-title":"Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Xuan","year":"2021","unstructured":"Xuan, L., Liu, Q. Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. J Hematol Oncol. 14 (1), 4 (2021).","journal-title":"J Hematol Oncol"},{"issue":"2","key":"ref5","first-page":"448","type":"journal-article","article-title":"Mesenchymal stem cells in osteoarthritis therapy: a review","volume":"13","author":"Zhu","year":"2021","unstructured":"Zhu, C., Wu, W., Qu, X. Mesenchymal stem cells in osteoarthritis therapy: a review. Am J Transl Res. 13 (2), 448-461 (2021).","journal-title":"Am J Transl Res"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.3390\/ijms24076405","type":"journal-article","article-title":"Knee osteoarthritis: Epidemiology, pathogenesis, and mesenchymal stem cells: What else is new? An update","volume":"24","author":"Giorgino","year":"2023","unstructured":"Giorgino, R. et al. Knee osteoarthritis: Epidemiology, pathogenesis, and mesenchymal stem cells: What else is new? An update. Int J Mol Sci. 24 (7), 6405 (2023).","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"114481","DOI":"10.1016\/j.addr.2022.114481","type":"journal-article","article-title":"Type 1 diabetes and engineering enhanced islet transplantation","volume":"189","author":"Jeyagaran","year":"2022","unstructured":"Jeyagaran, A. et al. Type 1 diabetes and engineering enhanced islet transplantation. Adv Drug Deliv Rev. 189, 114481 (2022).","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.3390\/cells10102676","type":"journal-article","article-title":"Mechanisms of stem cell therapy in spinal cord injuries","volume":"10","author":"Shinozaki","year":"2021","unstructured":"Shinozaki, M., Nagoshi, N., Nakamura, M., Okano, H. Mechanisms of stem cell therapy in spinal cord injuries. Cells. 10 (10), 2676 (2021).","journal-title":"Cells"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1474-4422(21)00464-6","type":"journal-article","article-title":"Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials","volume":"21","author":"Zipser","year":"2022","unstructured":"Zipser, C. M. et al. Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials. Lancet Neurol. 21 (7), 659-670 (2022).","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"102086","DOI":"10.1016\/j.pneurobio.2021.102086","type":"journal-article","article-title":"Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment","volume":"204","author":"Kim","year":"2021","unstructured":"Kim, S. W. et al. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment. Prog Neurobiol. 204 102086 (2021).","journal-title":"Prog Neurobiol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41420-023-01532-9","type":"journal-article","article-title":"Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke","volume":"9","author":"Nie","year":"2023","unstructured":"Nie, L. et al. Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke. Cell Death Discov. 9 (1), 215 (2023).","journal-title":"Cell Death Discov"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13619-022-00128-5","type":"journal-article","article-title":"The therapeutic prospects and challenges of human neural stem cells for the treatment of Alzheimer's Disease","volume":"11","author":"Yue","year":"2022","unstructured":"Yue, C., Feng, S., Chen, Y., Jing, N. The therapeutic prospects and challenges of human neural stem cells for the treatment of Alzheimer's Disease. Cell Regen. 11 (1), 28 (2022).","journal-title":"Cell Regen"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41420-021-00439-7","type":"journal-article","article-title":"Human pluripotent stem cell-derived alveolar organoids for modeling pulmonary fibrosis and drug testing","volume":"7","author":"Kim","year":"2021","unstructured":"Kim, J.-H. et al. Human pluripotent stem cell-derived alveolar organoids for modeling pulmonary fibrosis and drug testing. Cell Death Discov. 7 (1), 48 (2021).","journal-title":"Cell Death Discov"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13287-022-03181-8","type":"journal-article","article-title":"Stem cell-based therapy for pulmonary fibrosis","volume":"13","author":"Cheng","year":"2022","unstructured":"Cheng, W., Zeng, Y., Wang, D. Stem cell-based therapy for pulmonary fibrosis. Stem Cell Res Ther. 13 (1), 492 (2022).","journal-title":"Stem Cell Res Ther"},{"issue":"34","key":"ref15","doi-asserted-by":"crossref","first-page":"eadk2524","DOI":"10.1126\/sciadv.adk2524","type":"journal-article","article-title":"Lung cell transplantation for pulmonary fibrosis","volume":"10","author":"Milman Krentsis","year":"2024","unstructured":"Milman Krentsis, I. et al. Lung cell transplantation for pulmonary fibrosis. Sci Adv. 10 (34), eadk2524 (2024).","journal-title":"Sci Adv"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.stemcr.2021.10.015","type":"journal-article","article-title":"Disease modeling of pulmonary fibrosis using human pluripotent stem cell-derived alveolar organoids","volume":"16","author":"Suezawa","year":"2021","unstructured":"Suezawa, T. et al. Disease modeling of pulmonary fibrosis using human pluripotent stem cell-derived alveolar organoids. Stem Cell Rep. 16 (12), 2973-2987 (2021).","journal-title":"Stem Cell Rep"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1002\/cpz1.88","type":"journal-article","article-title":"Autologous induced pluripotent stem cell-based cell therapies: Promise, progress, and challenges","volume":"1","author":"Madrid","year":"2021","unstructured":"Madrid, M., Sumen, C., Aivio, S., Saklayen, N. Autologous induced pluripotent stem cell-based cell therapies: Promise, progress, and challenges. Curr Protoc. 1 (3), e88 (2021).","journal-title":"Curr Protoc"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1007\/s11033-020-05353-2","type":"journal-article","article-title":"Stem cell therapy: old challenges and new solutions","volume":"47","author":"Balistreri","year":"2020","unstructured":"Balistreri, C. R. et al. Stem cell therapy: old challenges and new solutions. Mol Biol Rep. 47 (4), 3117-3131 (2020).","journal-title":"Mol Biol Rep"},{"issue":"10082","key":"ref19","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","type":"journal-article","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","unstructured":"Richeldi, L., Collard, H. R., Jones, M. G. Idiopathic pulmonary fibrosis. Lancet. 389 (10082), 1941-1952 (2017).","journal-title":"Lancet"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MCP.0b013e328348744f","type":"journal-article","article-title":"Stem cell therapy in pulmonary fibrosis","volume":"17","author":"Tzouvelekis","year":"2011","unstructured":"Tzouvelekis, A., Antoniadis, A., Bouros, D. Stem cell therapy in pulmonary fibrosis. Curr Opin Pulm Med. 17 (5), 368-373 (2011).","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1513\/pats.200801-006AW","type":"journal-article","article-title":"Lung epithelial progenitor cells","volume":"5","author":"Rawlins","year":"2008","unstructured":"Rawlins, E. L. Lung epithelial progenitor cells. Proc Am Thorac Soc. 5 (6), 675-681 (2008).","journal-title":"Proc Am Thorac Soc"},{"issue":"29","key":"ref22","doi-asserted-by":"crossref","first-page":"eadg5358","DOI":"10.1126\/sciadv.adg5358","type":"journal-article","article-title":"Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice","volume":"9","author":"Han","year":"2023","unstructured":"Han, M.-M. et al. Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice. Sci Adv. 9 (29), eadg5358 (2023).","journal-title":"Sci Adv"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/sctm.19-0037","type":"journal-article","article-title":"First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline","volume":"9","author":"Averyanov","year":"2019","unstructured":"Averyanov, A. et al. First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline. Stem Cells Transl Med. 9 (1), 6-16 (2019).","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.chest.2016.10.061","type":"journal-article","article-title":"Allogeneic human mesenchymal stem cells in patients with idiopathic pulmonary fibrosis via intravenous delivery (AETHER): A phase I safety clinical trial","volume":"151","author":"Glassberg","year":"2017","unstructured":"Glassberg, M. K. et al. Allogeneic human mesenchymal stem cells in patients with idiopathic pulmonary fibrosis via intravenous delivery (AETHER): A phase I safety clinical trial. Chest. 151 (5), 971-981 (2017).","journal-title":"Chest"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"13183","DOI":"10.1038\/s41598-023-40531-9","type":"journal-article","article-title":"Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis","volume":"13","author":"Zhao","year":"2023","unstructured":"Zhao, X. et al. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis. Sci Rep. 13 (1), 13183 (2023).","journal-title":"Sci Rep"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1479-5876-11-171","type":"journal-article","article-title":"A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis","volume":"11","author":"Tzouvelekis","year":"2013","unstructured":"Tzouvelekis, A. et al. A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med. 11 (1), 171 (2013).","journal-title":"J Transl Med"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1479-5876-9-182","type":"journal-article","article-title":"Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal","volume":"9","author":"Tzouvelekis","year":"2011","unstructured":"Tzouvelekis, A. et al. Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal. J Transl Med. 9 (1), 182 (2011).","journal-title":"J Transl Med"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12931-023-02357-x","type":"journal-article","article-title":"Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis","volume":"24","author":"Choi","year":"2023","unstructured":"Choi, S. M. et al. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis. Respir Res. 24 (1), 68 (2023).","journal-title":"Respir Res"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jim-2017-000494","type":"journal-article","article-title":"Airway transplantation of adipose stem cells protects against bleomycin-induced pulmonary fibrosis","volume":"66","author":"Llontop","year":"2018","unstructured":"Llontop, P. et al. Airway transplantation of adipose stem cells protects against bleomycin-induced pulmonary fibrosis. J Investig Med. 66 (4), 739-746 (2018).","journal-title":"J Investig Med"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10753-019-01101-2","type":"journal-article","article-title":"The anti-fibrotic and anti-inflammatory potential of bone marrow-derived mesenchymal stem cells and nintedanib in bleomycin-induced lung fibrosis in rats","volume":"43","author":"Gad","year":"2020","unstructured":"Gad, E. S. et al. The anti-fibrotic and anti-inflammatory potential of bone marrow-derived mesenchymal stem cells and nintedanib in bleomycin-induced lung fibrosis in rats. Inflammation. 43 (1), 123-134 (2020).","journal-title":"Inflammation"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"L688","DOI":"10.1152\/ajplung.00148.2020","type":"journal-article","article-title":"Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia","volume":"320","author":"Aal Porzionato","year":"2021","unstructured":"Porzionato, A. et al. Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia. Am Jl Physiol Lung Cell Mol Physiol. 320 (5), L688-L704 (2021).","journal-title":"Am Jl Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"ref32","first-page":"e1504","type":"journal-article","article-title":"Non-invasive Intratracheal Instillation in Mice","volume":"5","author":"Ortiz-Mu\u00f1oz","year":"2015","unstructured":"Ortiz-Mu\u00f1oz, G., Looney, M. R. Non-invasive Intratracheal Instillation in Mice. Bio Protoc. 5 (12), e1504 (2015).","journal-title":"Bio Protoc"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.addr.2010.08.009","type":"journal-article","article-title":"Imaging of cellular therapies","volume":"62","author":"Srinivas","year":"2010","unstructured":"Srinivas, M. et al. Imaging of cellular therapies. Adv Drug Deliv Rev. 62 (11), 1080-1093 (2010).","journal-title":"Adv Drug Deliv Rev"},{"key":"ref34","type":"book","volume-title":"Medical Imaging in Clinical Practice","author":"Li","year":"2013","unstructured":"Li, Z., Tong, L., Zhao, H., He, Z. in Medical Imaging in Clinical Practice. (ed) Erondu, F. O. IntechOpen (2013)."},{"issue":"14","key":"ref35","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1088\/1361-6560\/aa6c99","type":"journal-article","article-title":"Magnetic particle imaging: from proof of principle to preclinical applications","volume":"62","author":"Knopp","year":"2017","unstructured":"Knopp, T., Gdaniec, N., M\u00f6ddel, M. Magnetic particle imaging: from proof of principle to preclinical applications. Phys Med Biol. 62 (14), R124-R178 (2017).","journal-title":"Phys Med Biol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcct.2012.04.007","type":"journal-article","article-title":"Fundamentals and applications of magnetic particle imaging","volume":"6","author":"Borgert","year":"2012","unstructured":"Borgert, J. et al. Fundamentals and applications of magnetic particle imaging. J Cardiovasc Computed Tomogr. 6 (3), 149-153 (2012).","journal-title":"J Cardiovasc Computed Tomogr"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"101003","DOI":"10.1016\/j.mtphys.2023.101003","type":"journal-article","article-title":"Principles and applications of magnetic nanomaterials in magnetically guided bioimaging","volume":"32","author":"Mohapatra","year":"2023","unstructured":"Mohapatra, J. et al. Principles and applications of magnetic nanomaterials in magnetically guided bioimaging. Mater Today Phys. 32, 101003 (2023).","journal-title":"Mater Today Phys"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1039\/c3nr00544e","type":"journal-article","article-title":"Magnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy","volume":"5","author":"Pablico-Lansigan","year":"2013","unstructured":"Pablico-Lansigan, M. H., Situ, S. F., Samia, A. C. S. Magnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy. Nanoscale. 5 (10), 4040-4055 (2013).","journal-title":"Nanoscale"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.18383\/j.tom.2015.00172","type":"journal-article","article-title":"Quantitative "hot-spot" imaging of transplanted stem cells using superparamagnetic tracers and magnetic particle imaging","volume":"1","author":"Bulte","year":"2015","unstructured":"Bulte, J. W. M. et al. Quantitative \"hot-spot\" imaging of transplanted stem cells using superparamagnetic tracers and magnetic particle imaging. Tomography. 1 (2), 91-97 (2015).","journal-title":"Tomography"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1021\/acsanm.8b00063","type":"journal-article","article-title":"Development of a trimodal contrast agent for acoustic and magnetic particle imaging of stem cells","volume":"1","author":"Lemaster","year":"2018","unstructured":"Lemaster, J. E., Chen, F., Kim, T., Hariri, A., Jokerst, J. V. Development of a trimodal contrast agent for acoustic and magnetic particle imaging of stem cells. ACS Appl Nano Mater. 1 (3), 1321-1331 (2018).","journal-title":"ACS Appl Nano Mater"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1039\/D2NR03684C","type":"journal-article","article-title":"Complementary early-phase magnetic particle imaging and late-phase positron emission tomography reporter imaging of mesenchymal stem cells in vivo","volume":"15","author":"Shalaby","year":"2023","unstructured":"Shalaby, N. et al. Complementary early-phase magnetic particle imaging and late-phase positron emission tomography reporter imaging of mesenchymal stem cells in vivo. Nanoscale. 15 (7), 3408-3418 (2023).","journal-title":"Nanoscale"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1021\/acsnano.9b08660","type":"journal-article","article-title":"Artificially engineered cubic iron oxide nanoparticle as a high-performance magnetic particle imaging tracer for stem cell tracking","volume":"14","author":"Wang","year":"2020","unstructured":"Wang, Q. et al. Artificially engineered cubic iron oxide nanoparticle as a high-performance magnetic particle imaging tracer for stem cell tracking. ACS Nano. 14 (2), 2053-2062 (2020).","journal-title":"ACS Nano"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"L887","DOI":"10.1152\/ajplung.00432.2005","type":"journal-article","article-title":"Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis","volume":"291","author":"Li","year":"2006","unstructured":"Li, X. et al. Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 291 (5), L887-L895 (2006).","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68477\/image-guided-vivo-tracking-transplanted-distal-lung-epithelial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:52:25Z","timestamp":1792594345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68477\/image-guided-vivo-tracking-transplanted-distal-lung-epithelial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":43,"journal-issue":{"issue":"220","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68477","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}